SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-09-000049
Filing Date
2009-08-04
Accepted
2009-08-04 16:17:24
Documents
6
Period of Report
2009-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 10Q prx10qedgard84.htm 10-Q 1181762
2 ASSET PURCHASE AGREEMENT qolaparedactedforedgarrevise.htm EX-10.1 327957
3 CERTIFICATION exhibit31ceocert.htm EX-31.1 7436
4 CERTIFICATION exhibit31cfocert.htm EX-31.2 7391
5 CERTIFICATION exhibit32ceo.htm EX-32.1 3146
6 CERTIFICATION exhibit32cfo.htm EX-32.2 3469
  Complete submission text file 0000878088-09-000049.txt   1532685
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 09983794
SIC: 2834 Pharmaceutical Preparations